NCT02393157
- Conditions
- Burkitt Lymphoma, CD20+ Lymphoblastic Lymphoma, DNA Virus Infections, +21 more
- Locations
-
- New York Medical College Valhalla, New York, United States
Clinical trial condition
Explore clinical trials studying Primary Mediastinal B-cell Lymphoma. Study availability and eligibility vary by location and protocol.
NCT02393157
NCT02631044
NCT00924326
NCT01953692
Not specified
NCT02669017
NCT00944567
NCT00558220
NCT04911478
NCT01599559